|
Friday, 25 June
2010 |
|
|
11:30 |
Buffet Lunch |
12:45
|
Welcome and Introduction |
|
|
MRI Technique, Safety Issues,
Contrast Media |
13:15 |
MR Imaging Technique:
State-of-the-Art Imaging at 1:5T |
|
Speaker: Donald G.
Mitchell, M.D. |
|
Sequences of the commonly
used protocols in body MRI
T1-weighted sequences
Chemical shift imaging
T2-weighted sequences
Strategies to capture the arterial phase
Importance of optimizing T1 contrast for
gadolinium-enhanced imaging
3D sequences for dynamic gadolinium-enhanced sequences |
|
|
13:50 |
MR Imaging Technique:
State-of-the-Art Imaging at 3:0T |
|
Speaker: Shahid M.
Hussain, M.D. |
|
Back to the basics:
comparison of the basic physics
Influence of SAR, susceptibility, and body shape
Challenges and solutions
Improved coils and parallel imaging applications
Sequence optimization
MultiTransmit technique |
|
|
14:25 |
Diffusion Imaging:
Body Applications |
|
Speaker: Dow-Mu Koh,
M.D., M.R.C.P. |
|
Sequence description and
optimization for body MRI
Applications for abdomen, pelvis, prostate, and breast
Treatment response and changes on diffusion
Pitfalls |
|
|
15:00 |
Break |
|
|
15:20 |
MRI Contrast Media
|
|
Speaker: Scott B. Reeder,
M.D., Ph.D. |
|
FDA approved contrast
media
Chemical structure and hemodynamics
Safety profile
Mode of injection
Methods to capture the arterial phase
Role of liver-specific contrast media |
|
|
15:55 |
Perfusion Imaging: Body
Applications |
|
Speaker: Dow-Mu Koh,
M.D., M.R.C.P. |
|
Sequence description and
optimization for body MRI
Applications for abdomen, pelvis, prostate, and breast
Treatment response and changes on perfusion
Pitfalls |
|
|
16:35 |
Adjourn |
|
|
18:00 - 19:30 |
Welcome Reception |
|
|
19:30 |
Free evening to explore
the sights and sounds of Omaha |
|
|
|
Saturday, 26 June
2010 |
|
|
07:00 - 07:45 |
Breakfast |
|
|
Liver and Pancreas |
08:00 |
MR Imaging of the Liver Cysts,
Hemangiomas, and Metastases |
|
Speaker: Shahid M.
Hussain, M.D. |
|
Appearance on T1-weighted
sequences
Role of in- and opposed phase imaging
Appearance on T2-weighted sequences
Enhancement patterns of cysts, hemangiomas, metastases
Role of liver specific contrast media
MRI verus CT |
|
|
08:45 |
MR Imaging of Fatty Liver,
Fibrosis, and Cirrhosis |
|
Speaker: Scott B. Reeder,
M.D., Ph.D. |
|
Focal versus diffuse fatty
liver
Concurrent fatty infiltration and iron deposition
NAFLD, NASH, fibrosis, and cirrhosis
Chemical shift imaging and Dixon methods
MR elastography
Quantification of iron overload
Quantification fatty content of the liver |
|
|
09:30 |
MR Imaging of Hepatocellular
Carcinomas |
|
Speaker: Shahid M.
Hussain, M.D. |
|
Role of in- and opposed
phase imaging
Role of T1-weighted sequences with long TE
Appearance on T2-weighted sequences
Enhancement patterns of HCC, FNH, and adenomas
What to do with tiny (<1cm) enhancing liver lesions in
cirrhosis
MRI versus CT |
|
|
10:10 |
Break |
|
|
10:30 |
Biliary Tree Disorders: How to
Evaluate MRI & MRCP |
|
Speaker: Kartik Jhaveri,
M.D. |
|
Review of MRCP techniques
in short
Common biliary tree diseases (stones, PSC, Carolis
disease)
Klatskin tumors: detection and staging
MRCP versus ERCP |
|
|
11:15 |
MR Imaging of the Pancreatic
Cystic
Masses |
|
Speaker: Donald G.
Mitchell, M.D. |
|
Overview of the common and
uncommon pancreatic cystic lesions
Appearance on T1, T2, and contrast enhanced images
Distinction benign and malignant lesions
Significance of the upstream and downstream dilatation
IPMN
MRI versus CT for pancreatic cystic lesions |
|
|
12:00
|
Lunch |
|
|
13:00 |
MR Imaging of the Pancreatic
Solid Masses |
|
Speaker: Kartik Jhaveri,
M.D. |
|
Appearance of the normal
pancreas and tumors on T1-weighted sequences
Appearance of the normal pancreas and tumors on
T2-weighted sequences
Solid pancreatic tumors (neuroendocrine, adenocarcinomas)
Focal pancreatitis versus pancreatic tumors
Staging (extent of main lesion, relationship with the
vessels, lymph nodes, liver metastasis)
MRI versus CT for pancreatic masses |
|
|
Genitourinary Tract |
13:45 |
Fast MR Imaging of Acute Abdomen
in Children and Adults |
|
Speaker:
Trevor J. Andrews, Ph.D. |
|
Patient preparation and
screening
Coils and patient positioning
Sequence selection and recent developments
Examples of common and uncommon acute abdominal conditions |
|
|
14:30 |
Break |
|
|
14:50 |
MR Imaging of the Prostate
Carcinoma |
|
Speaker: Masoom A. Haider,
M.D., F.R.C.P.C. |
|
Prostate anatomy (zonal
anatomy, anatomic spaces, neurvascular bundel)
Surface coil versus endorectal coil
Specific MR imaging sequences (MRS, DWI, Dynamic
contrast-enhanced imaging)
Post-processing of dynamic data sets
MRI appearance of the normal prostate and tumors
Lymph node and bony metastases
Prostate carcinoma and the relationship to PSA: current
concepts and controversies |
|
|
15:30 |
Break |
|
|
|
Vendor Session No CME
Credit |
15:35 |
SPECIAL VENDOR PRESENTATION:
Philips HealthCare |
|
|
|
|
16:45 |
Adjourn |
|
|
|
|
Sunday, 27 June 2010 |
|
|
7:00 7:45
|
Breakfast |
|
|
Womens Imaging |
08:00 |
Breast MRI: Technique
|
|
Speaker: Marko K.
Ivancevic, Ph.D. |
|
Patient preparation and
screening
Coils and coil positioning
Contrast media
Sequence selection
Dynamic imaging, post-processing, and interpretation
3T imaging using MultiTransmit
Role of MRI in relation to US and Mammography |
|
|
08:45 |
Breast MRI: Lesion Detection and
Characterization |
|
Speaker: Jan W. Casselman,
M.D. |
|
Appearance of normal
breast tissue on contrast-enhanced images
Appearance of normal breast tissue on T2
Common benign breast lesions
Common malignant breast lesions
Pitfalls |
|
|
09:30 |
Breast MRI: Challenging Cases
(continues from the
presentation above) |
|
Speaker: Jan W. Casselman,
M.D. |
|
Quiz and explanation
How to approach challenging cases |
|
|
10:10 |
Break |
|
|
10:30 |
MR Imaging of the Female Pelvis:
Technique |
|
Speaker: Patricia Noλl,
M.D., F.R.C.P.C. |
|
Patient preparation and
screening
Coils and coil positioning
Contrast media
Sequence selection
Dynamic imaging, post-processing, and interpretation |
|
|
11:10 |
MR Imaging of Gynecological
Malignancies |
|
Speaker: Patricia Noλl,
M.D., F.R.C.P.C. |
|
Cervical cancer: staging
and pitfalls
Endometrial cancer: staging and distinction from
adenomyosis and fibroids
Ovarian cancer: different types and distinction from
ovarian follicles and hemorrhagic cysts |
|
|
11:55 |
Closing remarks, boxed
lunch, and adjourn |
|
|